Login / Signup

Identification and Characterization of Fenofibrate-Induced Liver Injury.

Jawad AhmadJoseph A OdinPaul H HayashiNaga ChalasaniRobert J FontanaHuiman BarnhartElizabeth T CirulliDavid E KleinerJay H Hoofnagle
Published in: Digestive diseases and sciences (2017)
Liver injury after fenofibrate exposure occurs with variable latency, enzyme elevation, and histology. Although most cases are self-limited, severe injury and mortality can occur, particularly if drug withdrawal is delayed. Jaundice or abnormal laboratory tests during fenofibrate therapy should trigger prompt discontinuation.
Keyphrases
  • liver injury
  • drug induced
  • adverse drug
  • cardiovascular events
  • risk factors
  • cardiovascular disease